Serum vitamin B6 in schizophrenic and schizoaffective patients with and without tardive dyskinesia

Clinical Neuropharmacology

Volumn 23, Issue 4, 2000, Pages 212-215

  Miodownik, Chanoch ^a   Lerner, Vladimir ^a,b   Cohen, Hagit ^a   Kotler, Moshe ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b MENTAL HEALTH CENTER   (Israel)

Author keywords

Pyridoxal phosphate; Schizoaffective disorder; Schizophrenia; Serum vitamin B6 level; Tardive dyskinesia

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; NEUROLEPTIC AGENT; NORADRENALIN; PYRIDOXAL 5 PHOSPHATE; PYRIDOXINE; SEROTONIN;

ADULT; AGED; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOIDISM; SCHIZOPHRENIA; TARDIVE DYSKINESIA; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; BLOOD; CLINICAL TRIAL; DYSKINESIA; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; PYRIDOXINE; SCHIZOPHRENIA;

EID: 0033626232     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002826-200007000-00008     Document Type: Article

References (23)

1. Tardive dyskinesia
2. Progress in the treatment of tardive dyskinesia: Theory and practice
3. High-dose pyfidoxine in tardive dyskinesia
4. Preventive measure for tardive dyskinesia
5. Dyskinesies tardives: Role de la pyridoxine dans la prevention
6. Pyridoxine improves drug-induced parkinsonism and psychosis in a schizophrenic patient
7. Movement disorders and psychotic symptoms treated with pyridoxine: A case report
8. 6 in treatment of tardive dyskinesia: A preliminary case series study
9. Thiamine and pyridoxine lack in newly admitted psychiatric patients
10. Thiamine, riboflavin and pyridoxine deficiency in psychiatric in-patients
11. Plasma pyridoxal phosphate in anxiety disorders
12. 6 levels in depressed outpatients
13. Tryptophan and bladder cancer
14. 6: Nutritional and pharmaceutical usage, stability, bioavailability, antagonists, and safety
15. Radioenzymatic assay for direct measurement of plasma pyridoxal 5'-phosphate
16. Predicting the long-term risk in outpatients maintained on neuroleptic medications
17. Vitamins, megavitamin therapy, and the nervous system
18. Pineal indoleamine metabolism in pyridoxine-deficient rats
19. Effect of pyridoxine deficiency on aromatic L-amino acid decarboxylase in adult rat brain
20. Nonparallel changes in brain monoamines of pyridoxine-deficient growing rats